Prudential Financial Inc Celularity Inc Transaction History

Prudential Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.17 - $0.33 $2,856 - $5,544	-16,800 Reduced 48.28%	18,000 $4,000
Q2 2023 Aug 11, 2023	SELL	$0.42 - $0.81 $1,392 - $2,685	-3,315 Reduced 8.7%	34,800 $18,000
Q1 2023 May 12, 2023	BUY	$0.56 - $1.15 $21,344 - $43,832	38,115 New	38,115 $23,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.